medigraphic.com
SPANISH

Cirugía y Cirujanos

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 4

<< Back Next >>

Cir Cir 2005; 73 (4)

Ultrasonography with contrast agent for diagnosis of benign retroperitoneal cyst. Case report

Guzmán-Valdivia GG, Morinelli-Urustizaga A, Martínez-Sánchez S, Ortiz-Valdivia M
Full text How to cite this article

Language: Spanish
References: 9
Page: 303-305
PDF size: 115.86 Kb.


Key words:

ultrasound, contrast agent, abdominal tumor.

ABSTRACT

Intraabdominal tumors require precise diagnosis for patient preparation for optimal surgical procedure. For diagnosis of these lesions, the principal studies used are ultrasonography, computed axial tomography (CAT) and occasionally the use of magnetic resonance imaging, a study not always possible to accomplish in all hospitals. We present the case of a patient with a giant retroperitoneal cyst whose diagnosis was missed by means of conventional ultrasound and CAT. For this reason, we chose to use ultrasound with echography using contrast agent (Levovist) to determine if the tumor was dependent on the liver or pancreas. By means of this technique, we were able to make the diagnosis that the tumor did not depend on any organ, but rather was an independent retroperitoneal tumor. Final surgical and histopathological diagnosis was a retroperitoneal multilocular lymphangioma. We conclude that ultrasonography with contrast agent (Levovist) is an alternative method for studying intraabdominal tumors.


REFERENCES

  1. Goldberg BB, Liu JB, Burns PN, Merton DA, Forsberg F. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993;12:463-470.

  2. 2. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents. A review. Ultrasound Med Biol 1994;20:319-333.

  3. 3. Schwarz KQ, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R. Doppler enhancement with Levovist in multiple vascular regions. Radiology 1994;193:195-201.

  4. 4. Grant EG. Sonographic contrast agents in vascular imaging. Semin Ultrasound CT MR 2001;22:25-41.

  5. 5. Halpern EJ, Verkh L, Forsberg F, Gomella LG, Mattrey EF, Goldberg BB. Initial experience with contrast-enhanced sonography of the prostate. AJR 2000;174:1575-1580.

  6. 6. Ding H, Kudo M, Onda H, Nomura H, Haji S. Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound 2001:29:411-416.

  7. 7. Schroeder RJ, Maurer J, Zlowodoski M, Hidajat N, Schulmus D, Weber S, Felix R. Vascularization of malignant and benign skin tumors measured by D-galactose-based signal-enhanced color Doppler sonography. Acta Radiol 2001;42:294-301.

  8. 8. Orden MR, Gudmundsson S, Kirkinen P. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses. J Ultrasound Med 2001;19:783-788.

  9. 9. Uggowitzer M, Kugler C, Groll R, Mischinger HJ, Stacher R, Fickert P, Weiglein A. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist). Br J Radiol 1998;71:1026-1032.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Cir. 2005;73